Information:
Fel:
ID
44472
Beskrivning
Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT01102335
Länk
https://clinicaltrials.gov/show/NCT01102335
Nyckelord
Versioner (2)
- 2020-02-16 2020-02-16 -
- 2021-09-27 2021-09-27 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
27 september 2021
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Hepatocellular Carcinoma NCT01102335
Eligibility Hepatocellular Carcinoma NCT01102335
- StudyEvent: Eligibility
Similar models
Eligibility Hepatocellular Carcinoma NCT01102335
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Liver carcinoma
Item
hepatocellular carcinoma
boolean
C2239176 (UMLS CUI [1])
Transarterial Chemoembolization
Item
treated with transcatheter arterial chemoembolization (tace)
boolean
C3539919 (UMLS CUI [1])
Hepatitis B DNA Measurement | Alanine aminotransferase normal
Item
hbvdna > 10^3copies/ml, including alanine aminotransferase (alt) normal patient
boolean
C3641250 (UMLS CUI [1])
C0855620 (UMLS CUI [2])
C0855620 (UMLS CUI [2])
Life Expectancy
Item
expected survive time > 1 year
boolean
C0023671 (UMLS CUI [1])
HBV Marker Positive | Hepatitis B surface antigen positive | Hepatitis B surface antibody positive | Hepatitis B e antigen positive | Antibody to hepatitis Be antigen Positive | Hepatitis B core antibody positive
Item
hbv marker positive (anyone of hbsag, hbsab, hbeag, hbeab and hbcab)
boolean
C0019169 (UMLS CUI [1,1])
C0005516 (UMLS CUI [1,2])
C1514241 (UMLS CUI [1,3])
C0149709 (UMLS CUI [2])
C0149708 (UMLS CUI [3])
C0392390 (UMLS CUI [4])
C0312634 (UMLS CUI [5,1])
C1514241 (UMLS CUI [5,2])
C0262506 (UMLS CUI [6])
C0005516 (UMLS CUI [1,2])
C1514241 (UMLS CUI [1,3])
C0149709 (UMLS CUI [2])
C0149708 (UMLS CUI [3])
C0392390 (UMLS CUI [4])
C0312634 (UMLS CUI [5,1])
C1514241 (UMLS CUI [5,2])
C0262506 (UMLS CUI [6])
Antiviral Therapy
Item
antiviral therapy history
boolean
C0280274 (UMLS CUI [1])
Alanine aminotransferase measurement
Item
alanine aminotransferase (alt) >400 u/l
boolean
C0201836 (UMLS CUI [1])
Serum total bilirubin measurement
Item
serum total bilirubin > 50 μmol/l
boolean
C1278039 (UMLS CUI [1])
Hepatitis B DNA Measurement
Item
hbvdna > 10^9copies/ml
boolean
C3641250 (UMLS CUI [1])
Metastasis Extrahepatic | Main portal vein Embolus
Item
extrahepatic metastasis or main portal vein embolus
boolean
C0027627 (UMLS CUI [1,1])
C1517058 (UMLS CUI [1,2])
C1183135 (UMLS CUI [2,1])
C1704212 (UMLS CUI [2,2])
C1517058 (UMLS CUI [1,2])
C1183135 (UMLS CUI [2,1])
C1704212 (UMLS CUI [2,2])
Cardiac dysfunction | Pulmonary Dysfunction
Item
apparent cardiac or pulmonary dysfunction
boolean
C3277906 (UMLS CUI [1])
C1709770 (UMLS CUI [2])
C1709770 (UMLS CUI [2])
Liver function Child-Pugh Classification
Item
liver function: child b or child c
boolean
C0232741 (UMLS CUI [1,1])
C4050412 (UMLS CUI [1,2])
C4050412 (UMLS CUI [1,2])
Hepatitis C
Item
hcv infection
boolean
C0019196 (UMLS CUI [1])